Quality of well-being self-assessmentThis is a brief commentary in response to article-Jayadevappa et al. (Qual Life Res 19:711-729, 2010). The commentary draws attention to issues that complicate QoL assessments in generic and disease-specific measures and its association to the treatment....
The objective was to assess the influence of patients' weight in the cost of rheumatoid arthritis treatment with biologic drugs used in first line after no... JA Román Ivorra,J Ivorra,E Monte-Boquet,... - 《Reumatología Clínica》 被引量: 6发表: 2016年 THU0522Comparison of Cost- Efficacy...
Rheumatoid arthritis (RA) affects approximately 0.5% of adult Indian population. The last few decades have seen significant advances in the treatment of RA. Pari-pasu, the goals of treatment have moved from symptomatic relief and disease modification to remission and even possible cure. One major ...
Evaluation of the cost-effectiveness of rheumatoid arthritis treatment with biologic agents using the IORRA cohort databaseTanaka, EInoue, EHoshi, DKobayashi, ASugimoto, NShidara, KSato, EInoue, YSeto, YNakajima, A
The hope is that effort will be gathered not only from patients and physicians, but more importantly from government, to improve the care and treatment of patients with RA and to help reduce or avoid the considerable societal costs of RA. 展开 关键词: Cost-of-illness Functional disability ...
Early, aggressive treatment of rheumatoid arthritis (RA) improves outcomes but confers increased risk. Risk stratification to target aggressive treatment of high-risk individuals with early RA is considered important to optimize outcomes while minimizing clinical and monetary costs. Some advocate the additi...
Treatment Patterns, Direct Cost of Biologics, and Direct Medical Costs for Rheumatoid Arthritis Patients: A Real-World Analysis of Nationwide Japanese Claims ... Naonobu,Sugiyama,Yutaka,... - 《Clinical Therapeutics》 被引量: 1发表: 2016年 Treatment Patterns, Direct Cost of Biologics, and Direct...
The hope is that effort will be gathered not only from patients and physicians, but more importantly from government, to improve the care and treatment of patients with RA and to help reduce or avoid the considerable societal costs of RA. 展开 关键词: Rheumatoid arthritis Cost-of-illness ...
“Biologic treatment has totally changed the treatment of rheumatoid arthritis, and it has been used for the past 20 years,” Durez told attendees at the ACR/ARHP 2018 Annual Meeting. “Several studies have demonstrated that tapering the biologic treatment in patients who achieve low disease...